Acadia Pharmaceuticals - 004255108

Detailed investor-level table based on 13F positions.

Shareholders (13F)

Quarter: Q2 2014
13D/13G major owners: Ownership tab.
Methodology: Market value and % of portfolio use SEC reported VALUE ($000). For PUT/CALL positions this reflects reported underlying exposure, not premium cash paid/received. Details.
Rows: 0
Investor History Status Shares held Market value ($000) % of portfolio Previous % Rank Change in shares % change in shares Source Date reported
Berson & Corrado Investment Advisors, LLC History New 124,060 2,803 1.22% 1 +124,060 New Q2 2014 Jul 21, 2014